… studies used an initial six monthly injections of anti-VEGF agents. For example, the first
prospective randomised multicentre study, the Branch Retinal Vein Occlusion (… III VIBRANT study […

… Baseline demographics and BCVA (best corrected visual acuity) of eyes diagnosed with
RVO (retinal vein occlusion) and treated with either ranibizumab or aflibercept. …

… -year incidence in the Beaver Dam Study … Vein Occlusion Study to dichotomize CRVO into
perfused, non-perfused, or indeterminate (CVOS 1995a). This framework was useful for study …

… Purpose: The aim of this study was to compare responses to aflibercept treatment in age-based
groups of patients with macular edema following branch retinal vein occlusion (BRVO). …

… (RVO) is the second most common retinal vascular disorder following diabetic retinopathy, …
classified into central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) …

… Central retinal vein occlusion (CRVO), a common retinal vascular disorder, is characterised
by dilated and tortuous retinal veins with haemorrhages in all four quadrants of the retina.1 2 …

… Epidemiology and Risk Factors CRVOs occur three times less commonly than branch retinal
vein occlusion, and the cumulative 15-year incidence of CRVO is reported to be 0.5 % [1]. …

… In the present study, six of the 58 eyes (10.3%) showed retinal or … We excluded eyes in which
the occluded site was located … , we excluded eyes with hemicentral retinal vein occlusion, …

… reported prevalence rates were ranging from 0.3 to 0.9% [1,2,3], and the incidence rate of …
The 15-year cumulative incidence of BRVO was 1.8% [4]. Most vision-threatening …

… occlusion is at disc level in central and hemi-central vein occlusions, in branch retinal vein
occlusion (… The prevalences of BRVO and central retinal vein occlusion (CRVO) are about 0.6…